# Valneva SE (INRLF)

> Healthcare · FR · Reports in EUR

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/INRLF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | € 31.02M | € -32.19M | € -4.70M | € 210.30M | € 76.99M |
| 2025 | € 177.51M | € -117.08M | € -58.31M | € 207.25M | € 106.17M |
| 2024 | € 175.69M | € -12.69M | € -100.22M | € 216.31M | € 181.25M |
| 2023 | € 163.12M | € -107.63M | € -233.86M | € 208.82M | € 128.25M |
| 2022 | € 394.54M | € -156.46M | € -299.93M | € 152.38M | € 219.80M |
| 2021 | € 415.08M | € -87.56M | € -19.40M | € 114.66M | € 170.58M |
| 2020 | € 138.09M | € -80.60M | € 148.04M | € 105.45M | € 77.42M |
| 2019 | € 157.52M | € -2.18M | € -6.68M | € 85.22M | € 135.15M |
| 2018 | € 142.98M | € 4.13M | € 16.61M | € 57.60M | € 143.19M |
| 2017 | € 135.21M | € -14.74M | € 11.29M | € 71.50M | € 92.67M |
| 2016 | € 122.41M | € -64.01M | € 3.67M | € 82.50M | € 100.05M |
| 2015 | € 103.09M | € -27.13M | € -35.50M | € 102.26M | € 144.34M |
| 2014 | € 48.69M | € -34.65M | € -25.09M | € 73.15M | € 124.44M |
| 2013 | € 40.09M | € -31.74M | € -31.83M | € 71.28M | € 144.11M |
| 2012 | € 2.56M | € -9.74M | € -8.08M | € 6.71M | € 26.19M |
| 2011 | N/A | N/A | N/A | € 6.80M | € 40.45M |
| 2010 | N/A | N/A | N/A | € 6.80M | € 44.29M |
| 2009 | N/A | N/A | N/A | € 6.39M | € 22.53M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 2.73 |
| Liabilities / Eq | 3.85 |
| Current Ratio | 2.14 |

## Other views

- [Metrics](https://sponda.capital/en/INRLF.md)
- [Charts](https://sponda.capital/en/INRLF/charts.md)
- [Compare](https://sponda.capital/en/INRLF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.